KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease
Redox imbalance and persistent inflammation are the underlying causes of most chronic diseases. Mammalian cells have evolved elaborate mechanisms for restoring redox homeostasis and resolving acute inflammatory responses. One prominent mechanism is that of inducing the expression of antioxidant, ant...
Main Authors: | Sharadha Dayalan Naidu, Albena T. Dinkova-Kostova |
---|---|
Format: | Article |
Language: | English |
Published: |
The Royal Society
2020-06-01
|
Series: | Open Biology |
Subjects: | |
Online Access: | https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.200105 |
Similar Items
-
KEAP1/NRF2 as a druggable target
by: Dinkova-Kostova Albena T.
Published: (2023-01-01) -
Anti-Inflammatory Activity of Kurarinone Involves Induction of HO-1 via the KEAP1/Nrf2 Pathway
by: Sakiko Nishikawa, et al.
Published: (2020-09-01) -
A Quantitative Proteomics Approach to Gain Insight into NRF2-KEAP1 Skeletal Muscle System and Its Cysteine Redox Regulation
by: Rafay Abu, et al.
Published: (2021-10-01) -
The role of the Nrf2/Keap1 signaling cascade in mechanobiology and bone health
by: Carlie Priddy, et al.
Published: (2021-12-01) -
Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
by: Yun Pyo Kang, et al.
Published: (2019-05-01)